EP Patent

EP2272505B1 — Vardenafil Hydrochlorid Trihydrat enthaltende Tabletten

Assigned to Bayer Intellectual Property GmbH · Expires 2016-10-12 · 10y expired

What this patent protects

Patent listed against vardenafil-hydrochloride.

Drugs covered by this patent

vardenafil-hydrochloride (VARDENAFIL HYDROCHLORIDE)

Patent Metadata

Patent number: EP2272505B1
Jurisdiction: EP
Classification: —
Expires: 2016-10-12
Drug substance claim: No
Drug product claim: No
Assignee: Bayer Intellectual Property GmbH
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.